Acne vulgaris: Nutritional factors may be influencing psychological sequelae

Medical Hypotheses

Volumn 69, Issue 5, 2007, Pages 1080-1084

  Katzman, Martin ^a   Logan, Alan C ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Nutrition Research Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; FOLIC ACID; OMEGA 3 FATTY ACID; SELENIUM; ZINC;

ACNE VULGARIS; ANXIETY; ARTICLE; DEPRESSION; HUMAN; NUTRIENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; SUICIDAL BEHAVIOR;

ACNE VULGARIS; HUMANS; MENTAL DISORDERS; MODELS, BIOLOGICAL; NUTRITIONAL STATUS; RISK ASSESSMENT;

EID: 34548720874     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.02.037     Document Type: Article

References (60)

1. Briganti S., and Picardo M. Antioxidant activity, lipid peroxidation and skin diseases. What's new. J Eur Acad Dermatol Venereol 17 (2003) 663-669
2. Silverberg N.B., and Weinberg J.M. Rosacea and adult acne: a worldwide epidemic. Cutis 68 (2001) 85
3. Galobardes B., Davey Smith G., Jefferys M., and McCarron P. Has acne increased? Prevalence of acne history among university students between 1948 and 1968. The Glasgow Alumni Cohort Study. Br J Dermatol 152 (2005) 824-825
4. Magin P., Adams J., Heading G., Pond D., and Smith W. Psychological sequelae of acne vulgaris: results of a qualitative study. Can Fam Phys 52 (2006) 978-979
5. Purvis D., Robinson E., Merry S., and Watson P. Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. J Paediat Child Health 42 (2006) 793-796
6. Rapp D.A., Brenes G.A., Feldman S.R., Fleischer A.B., Graham G.F., Daily M., et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol 151 (2004) 183-189
7. Thomas D.R. Psychosocial effects of acne. J Cutan Med Surg 8 Suppl. 4 (2004) 3-5
8. Mallon E., Newton J.N., Klassen A., Stewart-Brown S.L., Ryan T.J., and Finlay A.Y. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 140 (1999) 672-676
9. Cunliffe W.J. Acne and unemployment. Br J Dermatol 115 (1986) 386
10. Molinsky H., and Rechenberger I. Psychosomatics of acne. Fortschr Med 95 (1977) 2149-2153
11. Levenson C.W. Zinc: the new antidepressant?. Nutr Rev 64 (2006) 39-42
12. Nowak G., Szewczyk B., and Pilc A. Zinc and depression. An update. Pharmacol Rep 57 (2005) 713-718
13. Benton D. Selenium intake, mood and other aspects of psychological functioning. Nutr Neurosci 5 (2002) 363-374
14. Shor-Posner G., Lecusay R., Miguez M.J., Moreno-Black G., Zhnag G., Rodriguez N., et al. Psychological burden in the era of HAART: impact of selenium therapy. Int J Psychiat Med 33 (2003) 55-69
15. Duntas L.H., Mantzou E., and Koutras D.A. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 148 (2003) 389-393
16. Abou-Saleh M.T., and Coppen A. Folic acid and the treatment of depression. J Psychosom Res 61 (2006) 285-287
17. Coppen A., and Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. J Affect Disord 60 (2000) 121-130
18. Docherty J.P., Sack D.A., Roffman M., Finch M., and Komorowski J.R. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J Psychiat Pract 11 (2005) 302-314
19. Davison J.R., Abraham K., Connor K.M., and McLeod M.N. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiat 53 (2003) 261-264
20. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiat 67 (2006) 1954-1967
21. Buydens L., Branchey M., and Roy A. N - 3 polyunsaturated fatty acids decrease feelings of anger in a population of substance abusers. Neuropsychopharmacology 30 (2005) S87-S88
22. Buydens-Branchey L., and Branchey M. n - 3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol 26 (2006) 661-665
23. Akhundov R.A., Sultanov A.A., Gadzhily R.A., and Sadykhov R.V. Psychoregulating role of nicotinamide. Biull Eksp Biol Med 115 (1993) 487-491
24. Michaelsson G., Vahlquist A., and Juhlin L. Serum zinc and retinol-binding protein in acne. Br J Dermatol 96 (1977) 283-286
25. Amer M., Bahgat M., Tosson Z., Mowla M., and Amer K. Serum zinc in acne vulgaris. Int J Dermatol 21 (1982) 481-484
26. Michaelsson G. Decreased concentration of selenium in whole blood and plasma in acne vulgaris. Acta Derm Venereol 70 (1990) 92
27. Michaelsson G., and Edqvist L.E. Erythrocyte glutathione peroxidase activity in acne vulgaris and the effect of selenium and vitamin E treatment. Acta Derm Venereol 64 (1984) 9-14
28. Niren N.M., and Torok H.M. The Nicomide Improvement in Clinical Outcomes Study (NICOS): results of an 8-week trial. Cutis 77 Suppl. 1 (2006) 17-28
29. Dreno B., Foulc P., Reynaud A., Moyse D., Habert H., and Richet H. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Eur J Dermatol 15 (2005) 152-155
30. McCarty M. High-chromium yeast for acne?. Med Hypotheses 14 (1984) 307-310
31. Jablonska S. Treatment of acne vulgaris and rosacea. Arch Dermatol 111 (1975) 929
32. Meynadier J. Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne. Eur J Dermatol 10 (2000) 269-273
33. Schaffer H. Essential fatty acids and eicosanoids in cutaneous inflammation. Int J Dermatol 28 (1989) 281-290
34. Logan A.C. Omega-3 fatty acids and acne. Arch Dermatol 139 (2003) 941-942 [author reply 942-3]
35. Hitch J.M., and Greenburg B.G. Adolescent acne and dietary iodine. Arch Dermatol 84 (1961) 898-911
36. Zouboulis C., Saborowski A., and Boschnakow A. Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production. Dermatology 210 (2005) 36-38
37. Zouboulis C., Nestoris S., Adler Y.D., Orth M., et al. A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor. Arch Dermatol 139 (2003) 668-670
38. James M.J., Gibson R.A., and Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71 Suppl. 1 (2000) 343S-348S
39. Panchaud A., Sauty A., Kernen Y., Decosterd D.A., et al. Biological effects of a dietary omega-3 polyunsaturated fatty acids supplementation in cystic fibrosis patients: a randomized, crossover placebo-controlled trial. Clin Nutr 25 (2006) 418-427
40. Ayres S., and Mihan R. Acne vulgaris and lipid peroxidation: new concepts in pathogenesis and treatment. Int J Dermatol 17 (1978) 305-307
41. Akamatsu H., and Horio T. The possible role of reactive oxygen species generated by neutrophils in mediating acne inflammation. Dermatology 196 (1998) 82-85
42. Arican O., Kurutas E.B., and Sasmaz S. Oxidative stress in patients with acne vulgaris. Mediat Inflamm 2005 (2005) 380-384
43. Arican O., Kurutas E.B., and Sasmaz S. Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris. Acta Dermatovenerol Alp Panonica Adriat 14 (2005) 39-42
44. Aybey B., Ergenekon G., Hekim N., Yarat A., Kurai Y., and Onsun N. Glutathione peroxidase (GSH-Px) enzyme levels of patients with acne vulgaris. J Eur Acad Dermatol Venereol 19 (2005) 766-767
45. El-Akawi Z., Abdel-Latif N., and Abdul-Razzak K. Does the plasma level of vitamins A and E affect acne condition?. Clin Exp Dermatol 31 (2006) 430-434
46. Tsuboi H., Shimoi K., Kinae N., Oguni I., Hori R., and Kobayashi F. Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. J Psychosom Res 56 (2004) 53-58
47. Atmaca M., Tezcan E., Kuloglu M., Ustungdag B., and Tunckol H. Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment. Eur Arch Psychiat Clin Neurosci 254 (2004) 231-235
48. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007 Feb 14 [Epub ahead of print].
49. Vignes M., Maurice T., Lante F., Nedjar M., et al. Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain Res 1110 (2006) 102-115
50. Barros D., Amaral O.B., Izquierdo I., Geracitano L., et al. Behavioral and genoprotective effects of vaccinium berries intake in mice. Pharmacol Biochem Behav 84 (2006) 229-234
51. Xu Y., Ku B., Tie L., Yao H., Jiang W., Ma X., et al. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res 1122 (2006) 56-64
52. Logan A.C., and Katzman M. Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses 64 (2005) 533-538
53. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 2006 Dec 6 [Epub ahead of print].
54. Volkova L.A., Khalif I.L., and Kabanova I.N. Impact of the impaired intestinal microflora on the course of acne vulgaris. Klin Med (Mosk) 79 (2001) 39-41
55. Marchetti F., Capizzi R., and Tulli A. Efficacy of regulators of the intestinal bacterial flora in the therapy of acne vulgaris. Clin Ter 122 (1987) 339-343
56. Siver R. Lactobacillus for the control of acne. J Med Soc New Jersey 58 (1961) 52-53
57. Amando J.M., Matos M.E., Abreu A.M., Loureiro L., Oliveira J., Verde A., et al. The prevalence of acne in the north of Portugal. J Eur Acad Dermatol Venereol 20 (2006) 1287-1295
58. Murray C.D., and Rhodes K. 'Nobody likes damaged goods': the experience of adult visible acne. Br J Health Psychol 10 (2005) 183-202
59. Pine D.S., Goldstein R.B., Wolk S., and Weissman M.M. The association between childhood depression and adulthood body mass index. Pediatrics 107 (2001) 1049-1056
60. Goodman E., and Whitaker R.C. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 110 (2002) 497-504